PIP
LMAT icon

Palisades Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Palisades Investment Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,453
Closed -$486K – 57
2026
Q1 		$486K Buy
4,453
+529
+13% +$50.4K 0.19% 49
2025
Q4 		$318K Buy
3,924
+459
+13% +$39.5K 0.12% 48
2025
Q3 		$303K Buy
+3,465
New +$309K 0.12% 47

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Palisades Investment Partners's LMAT Position: Q2 2026 in Review

Palisades Investment Partners sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 4,453 shares — an estimated $486K sold.

Palisades Investment Partners first reported a position in LMAT in Q3 2025 and held it in 3 quarters. The position peaked at $486K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Palisades Investment Partners reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Palisades Investment Partners sold 4,453 LeMaitre Vascular shares in Q2 2026, an estimated $486K.
  • Palisades Investment Partners first reported a position in LeMaitre Vascular in Q3 2025 and held it in 3 quarters.
  • Palisades Investment Partners's LeMaitre Vascular position peaked at $486K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Palisades Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.